ROCKVILLE, Md., Sept. 28, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Clinical Edge. Clinical Edge trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials. The combination of Optym, Emmes’ ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services. Emmes officially rolled out the new name – OptymEdge – and branding ahead of the American Academy of Ophthalmology annual meeting, which takes place in Chicago from September 30 to October 3. Emmes
The post Emmes Acquires Clinical Edge, Company’s Fifth Acquisition Deepens Ophthalmology Credentials and Enhances Global Reach appeared first on Pharma Mirror Magazine.
